Big Data Analytics in Big Pharma



Big Pharma Key Data Trends

Big Pharma Revenue Statements


Big Pharma Key Data Quarterly Trends

Big Pharma Main Data Quarterly Statements

Big Pharma Revenue Quarterly Statements


abbvie (NYSE: ABBV)

AbbVie Inc.
Industry: Biopharmaceutical


abbvie-logo


ABBV Key Data Trends


ABBV Key Data Quarterly Trends

ABBV Main Data Quarterly Statements


Abbott (NYSE: ABT)

ABBOTT LABORATORIES
Industry: Health care, Medical devices, Pharmaceutical


Abbott-logo


Period Opening price Closing price Growth rate Report date
2023Q3 95.450 114.000 19.43% 2023-10-18

ABT Key Data Trends


ABT Key Data Quarterly Trends

ABT Main Data Quarterly Statements


AMGEN (NASDAQ: AMGN)

Amgen Inc. (formerly Applied Molecular Genetics Inc.)
AMGEN INC
Industry: Biotechnology


AMGEN-logo


AMGN Key Data Trends


AMGN Key Data Quarterly Trends

AMGN Main Data Quarterly Statements


AstraZeneca (NASDAQ: AZN)

AstraZeneca PLC (AZ)
ASTRAZENECA PLC
United Kingdom
Industry: Pharmaceutical, Biotechnology


AstraZeneca-logo


Period Opening price Closing price Growth rate Report date
2024Q3 2024-11-12
2024Q2 76.140 64.790 -14.91% 2024-07-25
2024Q1 74.990 79.710 6.29% 2024-04-25
2023Q4 61.035 71.200 16.65% 2024-02-08


AZN Key Data Trends


AZN Key Data Quarterly Trends

AZN Main Data Quarterly Statements


Bristol Myers Squibb (NYSE: BMY)

BRISTOL-MYERS SQUIBB COMPANY, doing business as Bristol Myers Squibb (BMS)
BRISTOL MYERS SQUIBB CO
Industry: Pharmaceuticals


Bristol Myers Squibb-logo


BMY Key Data Trends


BMY Key Data Quarterly Trends

BMY Main Data Quarterly Statements


GILEAD (NASDAQ: GILD)

GILEAD SCIENCES, INC.
Industry: Pharmaceutics, Biotechnology

  Some rounding errors in the BS, IS, SOCF have been corrected.


GILEAD-logo


Period Opening price Closing price Growth rate Report date
2023Q3 80.320 76.710 -4.49% 2023-11-07

GILD Key Data Trends


GILD Key Data Quarterly Trends

GILD Main Data Quarterly Statements


Johnson&Johnson (NYSE: JNJ)

Johnson & Johnson (J&J)
JOHNSON & JOHNSON
Industry: Pharmaceutical, Medical Technology
  Fiscal year end: December 31


Johnson&Johnson-logo


JNJ Key Data Trends


JNJ Key Data Quarterly Trends

JNJ Main Data Quarterly Statements


Lilly (NYSE: LLY)

ELI LILLY AND COMPANY
ELI LILLY & Co
Industry: Pharmaceutical


Lilly-logo


Period Opening price Closing price Growth rate Report date
2024Q2 873.700 903.580 3.42% 2024-08-08
2023Q3 575.900 704.900 22.40% 2023-11-02
2023Q2 504.870 554.460 9.82% 2023-08-08

LLY Key Data Trends


LLY Key Data Quarterly Trends

LLY Main Data Quarterly Statements


MERCK (NYSE: MRK)

Merck & Co., Inc.
Industry: Pharmaceutical


MERCK-logo


Period Opening price Closing price Growth rate Report date
2023Q3 102.330 120.780 18.03% 2023-10-26

MRK Key Data Trends


MRK Key Data Quarterly Trends

MRK Main Data Quarterly Statements


novo nordisk (NYSE: NVO)

NOVO NORDISK A/S
NOVO NORDISK A S
Denmark
Industry: Pharmaceuticals, Health care
 Financial data: DKK
  Market cap: USD


novo nordisk-logo


Period Opening price Closing price Growth rate Report date
2024Q3 2024-11-06
2023Q3 101.280 109.020 7.64 2023-11-02
2023Q1 161.540 187.590 16.13% 2023-05-04

NVO Key Data Trends


NVO Key Data Quarterly Trends

NVO Main Data Quarterly Statements


NOVARTIS (NYSE: NVS)

Novartis AG
NOVARTIS AG
Switzerland
Industry: Pharmaceuticals


NOVARTIS-logo


NVS Key Data Trends


NVS Key Data Quarterly Trends

NVS Main Data Quarterly Statements


Pfizer (NYSE: PFE)

PFIZER INC.
PFIZER INC
Industry: Pharmaceutical, Biotechnology

  Some rounding errors in the BS, IS, SOCF have been corrected.


Pfizer-logo


PFE Key Data Trends


PFE Key Data Quarterly Trends

PFE Main Data Quarterly Statements


REGENERON (NASDAQ: REGN)

REGENERON PHARMACEUTICALS, INC.
Industry: Pharmaceuticals, Biotech


REGENERON-logo


Period Opening price Closing price Growth rate Report date
2023Q4 970.230 903.480 -6.88% 2024-02-02


REGN Key Data Trends


REGN Key Data Quarterly Trends

REGN Main Data Quarterly Statements


VERTEX (NASDAQ: VRTX)

Vertex Pharmaceuticals Incorporated
VERTEX PHARMACEUTICALS INC / MA
Industry: Pharmaceuticals, Biotherapeutics


VERTEX-logo


Period Opening price Closing price Growth rate Report date
2024Q3 2024-11-05


VRTX Key Data Trends


VRTX Key Data Quarterly Trends

VRTX Main Data Quarterly Statements


15 Comments

  1. (NYSE: NVS) (Quarterly) Report of foreign issuer 2024Q3

    ReplyDelete
  2. (NASDAQ: REGN) Quarterly report 2024Q3

    ReplyDelete
  3. (NASDAQ: VRTX) Quarterly report 2024Q3

    ReplyDelete
  4. (NYSE: NVO) (Quarterly) Report of foreign issuer 2024Q3

    ReplyDelete
  5. (NASDAQ: AZN, LSE: AZN) (Quarterly) Report of foreign issuer 2024Q3

    ReplyDelete
  6. (NASDAQ: GILD) Quarterly report 2024Q3

    ReplyDelete
  7. (NASDAQ: AMGN) Quarterly report 2024Q3

    ReplyDelete
  8. Big Pharma Revenue Quarterly Statements 2024Q3

    ReplyDelete

Post a Comment

Previous Post Next Post